Task V31: Process Development for a Panfungal Vaccine
- Institution
- ADVANCED BIOSCIENCE LABORATORIES, INC., MD
- Principal investigator
- Tim Fouts
- Funding
- $28K
- Duration
- 2023–2025
Moonbase score
Still being scored
Abstract
The Manufacture and Characterization Services (MCS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of services spanning product development planning and feasibility assessments; product optimization; product development and cGMP compliant manufacture for Phase I/II clinical studies; technical and facility audits; and regulatory support appropriate for submission to the U.S. Food and Drug Administration (FDA). These services will facilitate the development and introduction of new vaccines and biologics against antibacterial resistant pathogens. This contract also provides for manufacture of vaccines, vaccine components including adjuvants, vaccine delivery systems, other biologics, and challenge material.
LOADING MOONBASE SCORE
Questions for ADVANCED BIOSCIENCE LABORATORIES, INC.
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Advanced Bioscience Laboratories, Inc.Not yet scored
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support
Peter Silvera · $551K · 2025–2026
- NIH · Advanced Bioscience Laboratories, Inc.Not yet scored
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention
Timothy Fouts · $181K · 2025–2028
- NIH · Advanced Bioscience Laboratories, Inc.Not yet scored
NIAID Preclinical Development Support - Production of a HIV gp145 Clade C Trimer Protein
Timothy Fouts · $25K · 2025